StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Johnson & Johnson
NYSE:JNJ
Sector
Location
Market Cap
USD 375.37 B
Share Price
USD 155.27
Avg Daily Volume
9,317,871
Change (1 day)
-0.47%
Change (1 year)
6.00%
Change (YTD)
7.36%
Johnson & Johnson Revenue for the Trailing 12 Months (TTM) ending March 30, 2025: USD 89.33 B
Johnson & Johnson Revenue is USD 89.33 B for the Trailing 12 Months (TTM) ending March 30, 2025, a 4.30% change year over year. Revenue is the total amount of money generated from the sales of goods or services by a company during a specific period.
-
Johnson & Johnson Revenue for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 85.65 B, a -3.35% change year over year.
-
Johnson & Johnson Revenue for the Trailing 12 Months (TTM) ending April 02, 2023 was USD 88.62 B, a -6.60% change year over year.
-
Johnson & Johnson Revenue for the Trailing 12 Months (TTM) ending April 03, 2022 was USD 94.88 B, a 12.67% change year over year.
-
Johnson & Johnson Revenue for the Trailing 12 Months (TTM) ending April 04, 2021 was USD 84.21 B, a 1.80% change year over year.
Competitors
GSK plc
USD 18.98
GSK.L
-0.18
-0.96%
Haleon plc
USD 5.05
HLN.L
-0.10
-2.03%
Zhangzhou Pientzehuang Pharmaceutical., Ltd
USD 27.64
600436.SS
+0.16
0.57%
Yunnan Baiyao Group Co.,Ltd
USD 7.79
000538.SZ
+0.04
0.51%
Nahdi Medical Company
USD 34.61
4164.SR
+0.05
0.15%
Ajanta Pharma Limited
USD 30.80
AJANTPHARM.NS
-0.13
-0.41%
Rohto Pharmaceutical Co.,Ltd.
USD 13.97
4527.T
-0.12
-0.87%
Jamjoom Pharmaceuticals Factory Company
USD 44.97
4015.SR
+0.66
1.50%
Gerresheimer AG
USD 56.90
GXI.DE
-0.40
-0.69%
Zhejiang CONBA Pharmaceutical Co.,Ltd.
USD 0.62
600572.SS
+0.00
0.27%
Eli Lilly and Company
USD 772.87
LLY
-7.80
-1.00%
AbbVie Inc.
USD 187.63
ABBV
-1.65
-0.87%
Roche Holding AG
USD 342.25
RO.SW
-5.82
-1.67%
AstraZeneca PLC
USD 138.95
AZN.L
-2.01
-1.43%
Merck & Co., Inc.
USD 80.90
MRK
-0.03
-0.04%
Amgen Inc.
USD 292.95
AMGN
-5.29
-1.77%
Pfizer Inc.
USD 25.24
PFE
-0.14
-0.55%
Gilead Sciences, Inc.
USD 111.78
GILD
+0.03
0.03%
Sanofi
USD 96.52
SAN.PA
-1.52
-1.55%
Bristol-Myers Squibb Company
USD 46.49
BMY
-0.43
-0.92%
Key Data
| Date | Revenue | Revenue | Gross Profit | Operating Income |
|---|
Competitors
GSK plc
USD 18.98
GSK.L
-0.18
-0.96%
Haleon plc
USD 5.05
HLN.L
-0.10
-2.03%
Zhangzhou Pientzehuang Pharmaceutical., Ltd
USD 27.64
600436.SS
+0.16
0.57%
Yunnan Baiyao Group Co.,Ltd
USD 7.79
000538.SZ
+0.04
0.51%
Nahdi Medical Company
USD 34.61
4164.SR
+0.05
0.15%
Ajanta Pharma Limited
USD 30.80
AJANTPHARM.NS
-0.13
-0.41%
Rohto Pharmaceutical Co.,Ltd.
USD 13.97
4527.T
-0.12
-0.87%
Jamjoom Pharmaceuticals Factory Company
USD 44.97
4015.SR
+0.66
1.50%
Gerresheimer AG
USD 56.90
GXI.DE
-0.40
-0.69%
Zhejiang CONBA Pharmaceutical Co.,Ltd.
USD 0.62
600572.SS
+0.00
0.27%
Eli Lilly and Company
USD 772.87
LLY
-7.80
-1.00%
AbbVie Inc.
USD 187.63
ABBV
-1.65
-0.87%
Roche Holding AG
USD 342.25
RO.SW
-5.82
-1.67%
AstraZeneca PLC
USD 138.95
AZN.L
-2.01
-1.43%
Merck & Co., Inc.
USD 80.90
MRK
-0.03
-0.04%
Amgen Inc.
USD 292.95
AMGN
-5.29
-1.77%
Pfizer Inc.
USD 25.24
PFE
-0.14
-0.55%
Gilead Sciences, Inc.
USD 111.78
GILD
+0.03
0.03%
Sanofi
USD 96.52
SAN.PA
-1.52
-1.55%
Bristol-Myers Squibb Company
USD 46.49
BMY
-0.43
-0.92%